Familial Autoimmune Thyroid Disease as a Risk Factor for Regression in Children with Autism Spectrum Disorder: A CPEA Study

Center for Epidemiology and Biostatistics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Ohio 45229-3039, USA.
Journal of Autism and Developmental Disorders (Impact Factor: 3.34). 05/2006; 36(3):317-24. DOI: 10.1007/s10803-005-0071-0
Source: PubMed

ABSTRACT A multicenter study of 308 children with Autism Spectrum Disorder (ASD) was conducted through the Collaborative Programs of Excellence in Autism (CPEA), sponsored by the National Institute of Child Health and Human Development, to compare the family history of autoimmune disorders in children with ASD with and without a history of regression. A history of regression was determined from the results of the Autism Diagnostic Interview-Revised (ADI-R). Family history of autoimmune disorders was obtained by telephone interview. Regression was significantly associated with a family history of autoimmune disorders (adjusted OR=1.89; 95% CI: 1.17, 3.10). The only specific autoimmune disorder found to be associated with regression was autoimmune thyroid disease (adjusted OR=2.09; 95% CI: 1.28, 3.41).

  • Source
    • "This was first documented in case reports [20] and later confirmed in comprehensive epidemiological studies for approximately 40% of children with autism [21] [22]. In particular an association with autoimmune thyroiditis or hypothyroidism [23], rheumatic fever [24], rheumatoid arthritis, celiac disease, ulcerative colitis, psoriasis, family history of type 1 diabetes has been found [22] [25]. Some have suggested that these findings support further research into the possibility of an autoimmune component in ASD because, in general, in autoimmune diseases there is a higher prevalence of a family history of autoimmune disease. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Autism Spectrum Disorders (ASD) are a group of heterogeneous neurodevelopmental conditions presenting in early childhood with a prevalence ranging from 0.7% to 2.64%. Social interaction and communication skills are impaired and children often present with unusual repetitive behavior. The condition persists for life with major implications for the individual, the family and the entire health care system. While the etiology of ASD remains unknown, various clues suggest a possible association with altered immune responses and ASD. Inflammation in the brain and CNS has been reported by several groups with notable microglia activation and increased cytokine production in postmortem brain specimens of young and old individuals with ASD. Moreover several laboratories have isolated distinctive brain and CNS reactive antibodies from individuals with ASD. Large population based epidemiological studies have established a correlation between ASD and a family history of autoimmune diseases, associations with MHC complex haplotypes, and abnormal levels of various inflammatory cytokines and immunological markers in the blood. In addition, there is evidence that antibodies that are only present in some mothers of children with ASD bind to fetal brain proteins and may be a marker or risk factor for ASD. Studies involving the injection of these ASD specific maternal serum antibodies into pregnant mice during gestation, or gestational exposure of Rhesus monkeys to IgG subclass of these antibodies, have consistently elicited behavioral changes in offspring that have relevance to ASD. We will summarize the various types of studies associating ASD with the immune system, critically evaluate the quality of these studies, and attempt to integrate them in a way that clarifies the areas of immune and autoimmune phenomena in ASD research that will be important indicators for future research.
    Journal of Autoimmunity 07/2013; 44. DOI:10.1016/j.jaut.2013.05.005 · 7.02 Impact Factor
  • Source
    • "Trajectories of development that cannot be characterized as delayed but are clearly atypical turn out to be relatively rare and presumably imply more radical differences in the underlying neural constraints. Developmental regression is amongst the most atypical patterns observed, and its causes are currently unknown (Baird et al., 2008; Molloy et al., 2006). The inspiration for the current model was a recent hypothesis by Pickles et al. (2009) that pertained to regression in the form of loss of language in the early development of children with autism. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Loss of previously established behaviors in early childhood constitutes a markedly atypical developmental trajectory. It is found almost uniquely in autism and its cause is currently unknown (Baird et al., 2008). We present an artificial neural network model of developmental regression, exploring the hypothesis that regression is caused by overaggressive synaptic pruning and identifying the mechanisms involved. We used a novel population-modeling technique to investigate developmental deficits, in which both neurocomputational parameters and the learning environment were varied across a large number of simulated individuals. Regression was generated by the atypical setting of a single pruning-related parameter. We observed a probabilistic relationship between the atypical pruning parameter and the presence of regression, as well as variability in the onset, severity, behavioral specificity, and recovery from regression. Other neurocomputational parameters that varied across the population modulated the risk that an individual would show regression. We considered a further hypothesis that behavioral regression may index an underlying anomaly characterizing the broader autism phenotype. If this is the case, we show how the model also accounts for several additional findings: shared gene variants between autism and language impairment (Vernes et al., 2008); larger brain size in autism but only in early development (Redcay & Courchesne, 2005); and the possibility of quasi-autism, caused by extreme environmental deprivation (Rutter et al., 1999). We make a novel prediction that the earliest developmental symptoms in the emergence of autism should be sensory and motor rather than social and review empirical data offering preliminary support for this prediction.
    Psychological Review 08/2011; 118(4):637-54. DOI:10.1037/a0025234 · 7.72 Impact Factor
  • Source
    • "j.bbi.2010.09.002 2010) supporting a potential role for abnormal immune dysfunction in ASD. Moreover, associations with maternal autoimmunity (Comi et al., 1999; Croen et al., 2005; Molloy et al., 2006; Atladóttir et al., 2009) or maternal diagnosis of allergy/asthma in the second trimester of pregnancy (Croen et al., 2005) and an ASD diagnosis in the offspring, suggests that inappropriate maternal immune responses may alter the course of immune and neurodevelopment. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Autism spectrum disorders (ASD) are characterized by impairment in social interactions, communication deficits, and restricted repetitive interests and behaviors. A potential etiologic role for immune dysfunction in ASD has been suggested. Dynamic adaptive cellular immune function was investigated in 66 children with a confirmed diagnosis of ASD and 73 confirmed typically developing (TD) controls 2-5 years-of-age. In vitro stimulation of peripheral blood mononuclear cells with PHA and tetanus was used to compare group-associated cellular responses. The production of GM-CSF, TNFα, and IL-13 were significantly increased whereas IL-12p40 was decreased following PHA stimulation in ASD relative to TD controls. Induced cytokine production was associated with altered behaviors in ASD children such that increased pro-inflammatory or T(H)1 cytokines were associated with greater impairments in core features of ASD as well as aberrant behaviors. In contrast, production of GM-CSF and T(H)2 cytokines were associated with better cognitive and adaptive function. Following stimulation, the frequency of CD3(+), CD4(+) and CD8(+) T cells expressing activation markers CD134 and CD25 but not CD69, HLA-DR or CD137 were significantly reduced in ASD, and suggests an altered activation profile for T cells in ASD. Overall these data indicate significantly altered adaptive cellular immune function in children with ASD that may reflect dysfunctional immune activation, along with evidence that these perturbations may be linked to disturbances in behavior and developmental functioning. Further longitudinal analyzes of cellular immunity profiles would delineate the relationship between immune dysfunction and the progression of behavioral and developmental changes throughout the course of this disorder.
    Brain Behavior and Immunity 07/2011; 25(5):840-9. DOI:10.1016/j.bbi.2010.09.002 · 6.13 Impact Factor
Show more